Relationship of terminal duct lobular unit involution of the breast with area and volume mammographic densities

Cancer Prevention Research

Volumn 9, Issue 2, 2016, Pages 149-158

  Gierach, Gretchen L ^a   Patel, Deesha A ^a,e   Pfeiffer, Ruth M ^a   Figueroa, Jonine D ^a,f   Linville, Laura ^a,g   Papathomas, Daphne ^a   Johnson, Jason M ^c   Chicoine, Rachael E ^b   Herschorn, Sally D ^b   Shepherd, John A ^d   Wang, Jeff ^d,h   Malkov, Serghei ^d   Vacek, Pamela M ^b   Weaver, Donald L ^b   Fan, Bo ^d   Mahmoudzadeh, Amir Pasha ^d   Palakal, Maya ^a   Xiang, Jackie ^a   Oh, Hannah ^a   Horne, Hisani N ^a,i   Sprague, Brian L ^b   Hewitt, Stephen M ^a   Brinton, Louise A ^a   Sherman, Mark E ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

^g GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^h HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST DENSITY; CANCER GROWTH; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; TERMINAL DUCT LOBULAR UNIT BREAST INVOLUTION; TUMOR BIOPSY; VOLUME MAMMOGRAPHIC DENSITY; ABNORMALITIES; AGE; BREAST; BREAST NEOPLASMS; CANCER STAGING; CARCINOMA, LOBULAR; COMPLICATION; FOLLOW UP; MAMMARY GLAND; MAMMOGRAPHY; PATHOLOGY; PROGNOSIS; RISK FACTOR; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; BREAST; BREAST DENSITY; BREAST NEOPLASMS; CARCINOMA, LOBULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAMMARY GLANDS, HUMAN; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM STAGING; PREMENOPAUSE; PROGNOSIS; RISK FACTORS; TUMOR BURDEN;

EID: 84957932572     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-15-0282     Document Type: Article

References (40)

1. Martin LJ, Boyd NF. Mammographic density-Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res 2008; 10:201.
2. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns asmarkers of breast cancer risk: ameta-Analysis. Cancer Epidemiol Biomarkers Prev 2006;15:1159-69.
3. Russo J, Hu YF, Yang X, Russo IH. Developmental, cellular, and molecular basis of human breast cancer. J Natl Cancer Inst Monogr 2000:17-37.
4. Ghosh K, Hartmann LC, Reynolds C, Visscher DW, Brandt KR, Vierkant RA, et al. Association between mammographic density and age-related lobular involution of the breast. J Clin Oncol 2010;28:2207-12.
5. Ghosh K, Vachon CM, Pankratz VS, Vierkant RA, Anderson SS, Brandt KR, et al. Independent association of lobular involution and mammographic breast density with breast cancer risk. J Natl Cancer Inst 2010; 102:1716-23.
6. Ginsburg OM, Martin LJ, Boyd NF. Mammographic density, lobular involution, and risk of breast cancer. Br J Cancer 2008;99:1369-74.
7. Milanese TR, Hartmann LC, Sellers TA, FrostMH, Vierkant RA,Maloney SD, et al. Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst 2006;98:1600-7.
8. Baer HJ, Collins LC, Connolly JL, Colditz GA, Schnitt SJ, Tamimi RM. Lobule type and subsequent breast cancer risk: results from the Nurses' Health Studies. Cancer 2009;115:1404-11.
9. Hanna M, Dumas I, Jacob S, Tetu B, Diorio C. Physical activity, mammographic density, and age-related lobular involution among premenopausal and postmenopausal women. Menopause 2015;22:964-75.
10. Wolfe J. Breast patterns as an index of risk for developing breast cancer. Am J Roentgenol 1976;126:1130-9.
11. Byng JW, BoydNF, Fishell E, Jong RA, Yaffe MJ. The quantitative analysis of mammographic densities. Phys Med Biol 1994;39:1629-38.
12. Figueroa JD, Pfeiffer RM, Patel DA, Linville L, Brinton LA, Gierach GL, et al. Terminal duct lobular unit involution of the normal breast: implications for breast cancer etiology. J Natl Cancer Inst 2014;106; dju286.
13. Gierach GL, Geller BM, Shepherd JA, Patel DA, Vacek PM, Weaver DL, et al. Comparison of mammographic density assessed as volumes and areas among women undergoing diagnostic image-guided breast biopsy. Cancer Epidemiol Biomarkers Prev 2014;23:2338-48.
14. Pankratz VS, Degnim AC, Frank RD, Frost MH, Visscher DW, Vierkant RA, et al. Model for individualized prediction of breast cancer risk after a benign breast biopsy. J Clin Oncol 2015;33:923-9.
15. Gierach GL, Yang XR, Figueroa JD, Sherman ME. Emerging concepts in breast cancer risk prediction. Curr Obstet Gynecol Rep 2013;2:43-52.
16. Breastscreening.cancer.gov [Internet]. National Cancer Institute, U.S. National Institutes of Health, Bethesda, MD. [updated 2014 Feb 7; cited 2014 May 21]. Available from: http://breastscreening.cancer.gov/.
17. Yang XR, Figueroa JD, Falk RT, Zhang H, Pfeiffer RM, Hewitt SM, et al. Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers. Breast Cancer Res 2012;14:R64.
18. Rosebrock A, Caban JJ, Figueroa J, Gierach G, Linville L, Hewitt S, et al. Quantitative analysis of TDLUs using adaptive morphological shape techniques. Proc SPIE 2013;8676.
19. Khodr ZG, Sherman ME, Pfeiffer RM, Gierach GL, Brinton LA, Falk RT, et al. Circulating sex hormones and terminal duct lobular unit involution of the normal breast. Cancer Epidemiol Biomarkers Prev 2014;23: 2765-73.
20. Prevrhal S, Shepherd JA, Smith-Bindman R, Cummings SR, Kerlikowske K. Accuracy of mammographic breast density analysis: results of formal operator training. Cancer Epidemiol Biomarkers Prev 2002;11:1389-93.
21. Shepherd JA, Kerlikowske K,MaL, Duewer F, Fan B,Wang J, et al. Volume of mammographic density and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2011;20:1473-82.
22. Malkov S, Wang J, Kerlikowske K, Cummings SR, Shepherd JA. Single x-ray absorptiometry method for the quantitative mammographic measure of fibroglandular tissue volume. Med Phys 2009;36:5525-36.
23. Boyd N, Martin L, Stone J, Little L, Minkin S, Yaffe M. A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev 2002;11:1048-53.
24. Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
25. Jensen HM. On the origin and progression of human breast cancer. Am J Obstet Gynecol 1986;154:1280-4.
26. Sun X, Gierach GL, Sandhu R, Williams T, Midkiff BR, Lissowska J, et al. Relationship of mammographic density and gene expression: analysis of normal breast tissue surrounding breast cancer. Clin Cancer Res 2013; 19:4972-82.
27. Li T, Sun L, Miller N, Nicklee T, Woo J, Hulse-Smith L, et al. The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev 2005;14:343-9.
28. Sun X, Sandhu R, Figueroa JD, Gierach GL, Sherman ME, Troester MA. Benign breast tissue composition in breast cancer patients: associationwith risk factors, clinical variables, and gene expression. Cancer Epidemiol Biomarkers Prev 2014;23:2810-8.
29. Gertig DM, Stillman IE, Byrne C, Spiegelman D, Schnitt SJ, Connolly JL, et al. Association of age and reproductive factors with benign breast tissue composition. Cancer Epidemiol Biomarkers Prev 1999; 8:873-9.
30. Wang J, Azziz A, Fan B, Malkov S, Klifa C, Newitt D, et al. Agreement of mammographic measures of volumetric breast density to MRI. PLoS One 2013;8:e81653.
31. Eng A, Gallant Z, Shepherd J, McCormack V, Li J, Dowsett M, et al. Digital mammographic density and breast cancer risk: a case control study of six alternative density assessment methods. Breast Cancer Res 2014;16:439.
32. Boyd NF, Martin LJ, Bronskill M, Yaffe MJ, Duric N, Minkin S. Breast tissue composition and susceptibility to breast cancer. J Natl Cancer Inst 2010; 102:1224-37.
33. Vierkant RA, Hartmann LC, Pankratz VS, Anderson SS, Radisky D, Frost MH, et al. Lobular involution: localized phenomenon or field effect? Breast Cancer Res Treat 2009;117:193-6.
34. Vachon CM, Brandt KR, Ghosh K, Scott CG, Maloney SD, CarstonMJ, et al. Mammographic breast density as a general marker of breast cancer risk. Cancer Epidemiol Biomarkers Prev 2007;16:43-9.
35. Pinto Pereira SM, McCormack VA, Hipwell JH, Record C, Wilkinson LS, Moss SM, et al. Localized fibroglandular tissue as a predictor of future tumor location within the breast. Cancer Epidemiol Biomarkers Prev 2011;20:1718-25.
36. Ursin G, Hovanessian-Larsen L, Parisky Y, Pike M, Wu A. Greatly increased occurrence of breast cancers in areas of mammographically dense tissue. Breast Cancer Research 2005;7:R605-8.
37. Arnaout A, Robertson S, Kuchuk I, Simos D, Pond GR, Addison CL, et al. Evaluating the feasibility of performing window of opportunity trials in breast cancer. Int J Surg Oncol 2015;2015:785793.
38. Kalinsky K, Hershman DL. Cracking open window of opportunity trials. J Clin Oncol 2012;30:2573-5.
39. Cuzick J, Warwick J, Pinney E, Duffy SW, Cawthorn S, Howell A, et al. Tamoxifen-Induced reduction inmammographic density and breast cancer risk reduction: a nested case-control study. J Natl Cancer Inst 2011; 103:744-52.
40. Martinson HA, Lyons TR, Giles ED, Borges VF, Schedin P. Developmental windows of breast cancer risk provide opportunities for targeted chemoprevention. Exp Cell Res 2013;319:1671-8.